Literature DB >> 24678989

Timing and intensity of exposure to interferon-γ critically determines the function of monocyte-derived dendritic cells.

Sid P Kerkar1, Dhanalakshmi Chinnasamy, Neima Hadi, Jan Melenhorst, Pawel Muranski, Alexandros Spyridonidis, Sawa Ito, Gerrit Weber, Fang Yin, Nancy Hensel, Ena Wang, Francesco M Marincola, Austin John Barrett.   

Abstract

A growing body of evidence suggests that inflammatory cytokines have a dualistic role in immunity. In this study, we sought to determine the direct effects of interferon-γ (IFN-γ) on the differentiation and maturation of human peripheral blood monocyte-derived dendritic cells (moDC). Here, we report that following differentiation of monocytes into moDC with granulocyte-macrophage colony-stimulating factor and interleukin-4, IFN-γ induces moDC maturation and up-regulates the co-stimulatory markers CD80/CD86/CD95 and MHC Class I, enabling moDC to effectively generate antigen-specific CD4(+) and CD8(+) T-cell responses for multiple viral and tumour antigens. Early exposure of monocytes to high concentrations of IFN-γ during differentiation promotes the formation of macrophages. However, under low concentrations of IFN-γ, monocytes continue to differentiate into dendritic cells possessing a unique gene-expression profile, resulting in impairments in subsequent maturation by IFN-γ or lipopolysaccharide and an inability to generate effective antigen-specific CD4(+) and CD8(+) T-cell responses. These findings demonstrate that IFN-γ imparts differential programmes on moDC that shape the antigen-specific T-cell responses they induce. Timing and intensity of exposure to IFN-γ can therefore determine the functional capacity of moDC. Published 2014. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  T lymphocytes; antigen presentation; dendritic cells; inflammation; interferon-γ

Mesh:

Substances:

Year:  2014        PMID: 24678989      PMCID: PMC4137959          DOI: 10.1111/imm.12292

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  56 in total

1.  Are dendritic cells afraid of commitment?

Authors:  Anne O'Garra; Giorgio Trinchieri
Journal:  Nat Immunol       Date:  2004-12       Impact factor: 25.606

2.  Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals.

Authors:  Ann M Leen; G Doug Myers; Uluhan Sili; M Helen Huls; Heidi Weiss; Kathryn S Leung; George Carrum; Robert A Krance; Chung-Che Chang; Jeffrey J Molldrem; Adrian P Gee; Malcolm K Brenner; Helen E Heslop; Cliona M Rooney; Catherine M Bollard
Journal:  Nat Med       Date:  2006-09-24       Impact factor: 53.440

Review 3.  What does the future hold for cell-based tolerogenic therapy?

Authors:  Jeffrey A Bluestone; Angus W Thomson; Ethan M Shevach; Howard L Weiner
Journal:  Nat Rev Immunol       Date:  2007-08       Impact factor: 53.106

4.  A direct role for IFN-gamma in regulation of Th1 cell development.

Authors:  L M Bradley; D K Dalton; M Croft
Journal:  J Immunol       Date:  1996-08-15       Impact factor: 5.422

Review 5.  Cellular responses to interferon-gamma.

Authors:  U Boehm; T Klamp; M Groot; J C Howard
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

Review 6.  Unraveling the pros and cons of interferon-gamma gene regulation.

Authors:  Howard A Young
Journal:  Immunity       Date:  2006-05       Impact factor: 31.745

Review 7.  Taking dendritic cells into medicine.

Authors:  Ralph M Steinman; Jacques Banchereau
Journal:  Nature       Date:  2007-09-27       Impact factor: 49.962

Review 8.  The molecular cell biology of interferon-gamma and its receptor.

Authors:  M A Farrar; R D Schreiber
Journal:  Annu Rev Immunol       Date:  1993       Impact factor: 28.527

9.  Interferon-like virus-inhibitor induced in human leukocytes by phytohemagglutinin.

Authors:  E F Wheelock
Journal:  Science       Date:  1965-07-16       Impact factor: 47.728

10.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.

Authors:  F Sallusto; A Lanzavecchia
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

View more
  9 in total

Review 1.  The Biology and Underlying Mechanisms of Cross-Presentation of Exogenous Antigens on MHC-I Molecules.

Authors:  Freidrich M Cruz; Jeff D Colbert; Elena Merino; Barry A Kriegsman; Kenneth L Rock
Journal:  Annu Rev Immunol       Date:  2017-01-11       Impact factor: 28.527

2.  CD8 engineered cytotoxic T cells reprogram melanoma tumor environment.

Authors:  Julie Leignadier; Stephanie Favre; Sanjiv A Luther; Immanuel F Luescher
Journal:  Oncoimmunology       Date:  2015-09-11       Impact factor: 8.110

Review 3.  Generation, Characteristics and Clinical Trials of Ex Vivo Generated Tolerogenic Dendritic Cells.

Authors:  Sang Hyun Kim; Ho Hyun Jung; Chong Kil Lee
Journal:  Yonsei Med J       Date:  2018-09       Impact factor: 2.759

4.  Identification of New Soluble Factors Correlated With the Development of Graft Failure After Haploidentical Hematopoietic Stem Cell Transplantation.

Authors:  Gerrit Weber; Luisa Strocchio; Francesca Del Bufalo; Mattia Algeri; Daria Pagliara; Claudia Manuela Arnone; Biagio De Angelis; Concetta Quintarelli; Franco Locatelli; Pietro Merli; Ignazio Caruana
Journal:  Front Immunol       Date:  2021-01-29       Impact factor: 7.561

5.  Blockage of indoleamine 2,3-dioxygenase regulates Japanese encephalitis via enhancement of type I/II IFN innate and adaptive T-cell responses.

Authors:  Seong Bum Kim; Jin Young Choi; Erdenebileg Uyangaa; Ajit Mahadev Patil; Ferdaus Mohd Altaf Hossain; Jin Hur; Sang-Youel Park; John-Hwa Lee; Koanhoi Kim; Seong Kug Eo
Journal:  J Neuroinflammation       Date:  2016-04-18       Impact factor: 8.322

Review 6.  Generation of Tolerogenic Dendritic Cells and Their Therapeutic Applications.

Authors:  Seungbo Yoo; Sang-Jun Ha
Journal:  Immune Netw       Date:  2016-02-25       Impact factor: 6.303

7.  Amelioration of Japanese encephalitis by blockage of 4-1BB signaling is coupled to divergent enhancement of type I/II IFN responses and Ly-6C(hi) monocyte differentiation.

Authors:  Seong Bum Kim; Jin Young Choi; Jin Hyoung Kim; Erdenebelig Uyangaa; Ajit Mahadev Patil; Sang-Youel Park; John Hwa Lee; Koanhoi Kim; Young Woo Han; Seong Kug Eo
Journal:  J Neuroinflammation       Date:  2015-11-24       Impact factor: 8.322

8.  Review and Meta-Analyses of TAAR1 Expression in the Immune System and Cancers.

Authors:  Lisa M Fleischer; Rachana D Somaiya; Gregory M Miller
Journal:  Front Pharmacol       Date:  2018-06-26       Impact factor: 5.810

9.  Differential Modulation of Human Innate Lymphoid Cell (ILC) Subsets by IL-10 and TGF-β.

Authors:  Sandra Bonne-Année; Mabel C Bush; Thomas B Nutman
Journal:  Sci Rep       Date:  2019-10-04       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.